Epic Medical Research - Plano

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Fatty liver disease (MASLD/MASH)1 trial
• Peripheral artery disease1 trial

Phase

• Phase 32 trials

Status

• Recruiting2 trials

Lead sponsor

• Boehringer Ingelheim1 trial
• Regeneron Pharmaceuticals1 trial

Running trials

• Recruiting

  Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

  NCT07318610· Phase 3· Regeneron Pharmaceuticals· Source

  Contact: Clinical Trials Administrator

• Recruiting

  LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

  NCT06632444· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fatty liver disease (MASLD/MASH)1 recruiting
• Peripheral artery disease1 recruiting